{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T18:06:24Z","timestamp":1743789984345},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1038\/s41409-019-0625-y","type":"journal-article","created":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T17:02:31Z","timestamp":1565024551000},"page":"2072-2080","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Quantitative characterization of T-cell repertoire alteration in Chinese patients with B-cell acute lymphocyte leukemia after CAR-T therapy"],"prefix":"10.1038","volume":"54","author":[{"given":"Xiujian","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongxian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoqing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huarui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuyu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binsheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunyun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,5]]},"reference":[{"key":"625_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1126\/science.aaa4967","volume":"348","author":"SA Rosenberg","year":"2015","unstructured":"Rosenberg SA, Restifo NP. Adoptive cell transfer as personalized immunotherapy for human cancer. Science. 2015;348:62\u20138.","journal-title":"Science"},{"key":"625_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nature22395","volume":"545","author":"M Sadelain","year":"2017","unstructured":"Sadelain M, RiviSre I, Riddell S. Therapeutic T cell engineering. Nature. 2017;545:423\u201331.","journal-title":"Nature"},{"issue":"6258","key":"625_CR3","doi-asserted-by":"publisher","first-page":"aab4077","DOI":"10.1126\/science.aab4077","volume":"350","author":"C.-Y. Wu","year":"2015","unstructured":"Wu CY, Roybal KT, Puchner EM, Onuffer J, Lim WA. Remote control of therapeutic T cells through a small molecule-gated chimeric receptor. Science 2015;350:aab4077.","journal-title":"Science"},{"key":"625_CR4","doi-asserted-by":"crossref","unstructured":"Brentjens RJ, Davila ML, Riviere I, Park J, Wang XY, Cowell LG, et al. CD19-Targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Sci Transl Med. 2013;5:177ra38.","DOI":"10.1126\/scitranslmed.3005930"},{"key":"625_CR5","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0140-6736(14)61403-3","volume":"385","author":"DW Lee","year":"2015","unstructured":"Lee DW, Kochenderfer JN, Stetler-Stevenson M, Cui YZK, Delbrook C, Feldman SA, et al. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial. Lancet. 2015;385:517\u201328.","journal-title":"Lancet"},{"key":"625_CR6","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","volume":"371","author":"SL Maude","year":"2014","unstructured":"Maude SL, Frey N, Shaw PA, Aplenc R, Barrett DM, Bunin NJ, et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. New Engl J Med. 2014;371:1507\u201317.","journal-title":"New Engl J Med"},{"key":"625_CR7","doi-asserted-by":"crossref","unstructured":"Davila ML, Riviere I, Wang XY, Bartido S, Park J, Curran K, et al. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. Sci Transl Med. 2014;6:224ra25.","DOI":"10.1126\/scitranslmed.3008226"},{"key":"625_CR8","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1158\/1078-0432.CCR-16-1799","volume":"23","author":"YX Hu","year":"2017","unstructured":"Hu YX, Wu Z, Luo Y, Shi JM, Yu J, Pu CF, et al. Potent anti-leukemia activities of chimeric antigen receptor-modified T cells against CD19 in chinese patients with relapsed\/refractory acute lymphocytic leukemia. Clin Cancer Res. 2017;23:3297\u2013306.","journal-title":"Clin Cancer Res"},{"key":"625_CR9","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.4049\/jimmunol.0900721","volume":"183","author":"A Barber","year":"2009","unstructured":"Barber A, Sentman CL. Chimeric NKG2D T cells require both T cell- and host-derived cytokine secretion and perforin expression to increase tumor antigen presentation and systemic immunity. J Immunol. 2009;183:2365\u201372.","journal-title":"J Immunol"},{"key":"625_CR10","doi-asserted-by":"publisher","first-page":"6939","DOI":"10.4049\/jimmunol.0902000","volume":"183","author":"A Barber","year":"2009","unstructured":"Barber A, Rynda A, Sentman CL. Chimeric NKG2D Expressing T cells eliminate immunosuppression and activate immunity within the ovarian tumor microenvironment. J Immunol. 2009;183:6939\u201347.","journal-title":"J Immunol"},{"issue":"4","key":"625_CR11","doi-asserted-by":"publisher","first-page":"e23564","DOI":"10.4161\/onci.23564","volume":"2","author":"Paul Spear","year":"2013","unstructured":"Spear P, Barber A, Sentman CL. Collaboration of chimeric antigen receptor (CAR)-expressing T cells and host T cells for optimal elimination of established ovarian tumors. Oncoimmunology. 2013;2:e23564.","journal-title":"OncoImmunology"},{"key":"625_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nri1292","volume":"4","author":"J Nikolich-Zugich","year":"2004","unstructured":"Nikolich-Zugich J, Slifka MK, Messaoudi I. The many important facets of T-cell repertoire diversity. Nat Rev Immunol. 2004;4:123\u201332.","journal-title":"Nat Rev Immunol"},{"key":"625_CR13","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.3892\/ol.2016.4465","volume":"11","author":"K Tamura","year":"2016","unstructured":"Tamura K, Hazama S, Yamaguchi R, Imoto S, Takenouchi H, Inoue Y, et al. Characterization of the T cell repertoire by deep T cell receptor sequencing in tissues and blood from patients with advanced colorectal cancer. Oncol Lett. 2016;11:3643\u20139.","journal-title":"Oncol Lett"},{"key":"625_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/ni.2190","volume":"13","author":"GP Morris","year":"2012","unstructured":"Morris GP, Allen PM. How the TCR balances sensitivity and specificity for the recognition of self and pathogens. Nat Immunol. 2012;13:121\u20138.","journal-title":"Nat Immunol"},{"key":"625_CR15","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1126\/science.286.5441.958","volume":"286","author":"TP Arstila","year":"1999","unstructured":"Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P. A direct estimate of the human alphabeta T cell receptor diversity. Science. 1999;286:958\u201361.","journal-title":"Science"},{"key":"625_CR16","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1126\/science.288.5469.1135a","volume":"288","author":"TP Arstila","year":"2000","unstructured":"Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P. Diversity of human alpha beta T cell receptors. Science. 2000;288:1135.","journal-title":"Science"},{"key":"625_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/imr.12140","volume":"257","author":"C Linnemann","year":"2014","unstructured":"Linnemann C, Mezzadra R, Schumacher TNM. TCR repertoires of intratumoral T-cell subsets. Immunol Rev. 2014;257:72\u201382.","journal-title":"Immunol Rev"},{"key":"625_CR18","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/nm.3359","volume":"19","author":"C Linnemann","year":"2013","unstructured":"Linnemann C, Heemskerk B, Kvistborg P, Kluin RJC, Bolotin DA, Chen XJ. et al. High-throughput identification of antigen-specific TCRs by TCR gene capture. Nat Med. 2013;19:1534\u201341.","journal-title":"Nat Med"},{"issue":"12","key":"625_CR19","doi-asserted-by":"publisher","first-page":"e968467","DOI":"10.4161\/21624011.2014.968467","volume":"3","author":"Hua Fang","year":"2014","unstructured":"Fang H, Yamaguchi R, Liu X, Daigo Y, Yew PY, Tanikawa C, et al. Quantitative T cell repertoire analysis by deep cDNA sequencing of T cell receptor alpha and beta chains using next-generation sequencing (NGS). Oncoimmunology. 2014;3:e968467.","journal-title":"OncoImmunology"},{"issue":"5","key":"625_CR20","doi-asserted-by":"publisher","first-page":"e1002728","DOI":"10.1080\/2162402X.2014.1002728","volume":"4","author":"Xiao Liu","year":"2015","unstructured":"Liu X, Venkataraman G, Lin JY, Kiyotani K, Smith S, Montoya M, et al. Highly clonal regulatory T-cell population in follicular lymphoma\u2014inverse correlation with the diversity of CD8(+) T cells. Oncoimmunology 2015;4:e1002728.","journal-title":"OncoImmunology"},{"key":"625_CR21","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/j.molonc.2015.09.003","volume":"9","author":"I Kirsch","year":"2015","unstructured":"Kirsch I, Vignali M, Robins H. T-cell receptor profiling in cancer. Mol Oncol. 2015;9:2063\u201370.","journal-title":"Mol Oncol"},{"key":"625_CR22","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/path.4260","volume":"231","author":"RO Emerson","year":"2013","unstructured":"Emerson RO, Sherwood AM, Rieder MJ, Guenthoer J, Williamson DW, Carlson CS, et al. High-throughput sequencing of T-cell receptors reveals a homogeneous repertoire of tumour-infiltrating lymphocytes in ovarian cancer. J Pathol. 2013;231:433\u201340.","journal-title":"J Pathol"},{"key":"625_CR23","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1158\/2326-6066.CIR-15-0240","volume":"4","author":"MS Hsu","year":"2016","unstructured":"Hsu MS, Sedighim S, Wang TN, Antonios JP, Everson RG, Tucker AM, et al. TCR sequencing can identify and track glioma-infiltrating T cells after DC vaccination. Cancer Immunol Res. 2016;4:412\u20138.","journal-title":"Cancer Immunol Res"},{"key":"625_CR24","unstructured":"Liu X, Kline J. Selection and Monitoring of Patients for Immunotherapy (PeptideVaccines). In: Nakamura Y (ed). Immunopharmacogenomics. Springer Japan: Tokyo, 2015, pp 63\u201384."},{"issue":"8","key":"625_CR25","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/s10038-018-0468-1","volume":"63","author":"Makda Zewde","year":"2018","unstructured":"Zewde M, Kiyotani K, Park JH, Fang H, Yap KL, Yew PY, et al. The era of immunogenomics\/immunopharmacogenomics. J Hum Genet 2018. https:\/\/doi.org\/10.1038\/s10038-018-0468-1","journal-title":"Journal of Human Genetics"},{"issue":"238","key":"625_CR26","doi-asserted-by":"publisher","first-page":"238ra70","DOI":"10.1126\/scitranslmed.3008211","volume":"6","author":"E. Cha","year":"2014","unstructured":"Cha E, Klinger M, Hou YF, Cummings C, Ribas A, Faham M, et al. Improved survival with T cell clonotype stability after anti-CTLA-4 treatment in cancer patients. Sci Transl Med. 2014;6:238ra70.","journal-title":"Science Translational Medicine"},{"key":"625_CR27","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1158\/0008-5472.CAN-15-3173","volume":"76","author":"N Sheikh","year":"2016","unstructured":"Sheikh N, Cham J, Zhang L, DeVries T, Letarte S, Pufnock J, et al. Clonotypic diversification of intratumoral T cells following sipuleucel-T treatment in prostate cancer subjects. Cancer Res. 2016;76:3711\u20138.","journal-title":"Cancer Res"},{"key":"625_CR28","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1158\/1078-0432.CCR-13-2648","volume":"20","author":"L Robert","year":"2014","unstructured":"Robert L, Tsoi J, Wang XY, Emerson R, Homet B, Chodon T, et al. CTLA4 blockade broadens the peripheral T-cell receptor repertoire. Clin Cancer Res. 2014;20:2424\u201332.","journal-title":"Clin Cancer Res"},{"key":"625_CR29","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/bmt.2015.133","volume":"50","author":"PY Yew","year":"2015","unstructured":"Yew PY, Alachkar H, Yamaguchi R, Kiyotani K, Fang H, Yap KL, et al. Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transpl. 2015;50:1227\u201334.","journal-title":"Bone Marrow Transpl"},{"key":"625_CR30","doi-asserted-by":"crossref","unstructured":"Zhang L, Cham J, Paciorek A, Trager J, Sheikh N, Fong L. 3D: diversity, dynamics, differential testing a proposed pipeline for analysis of next-generation sequencing T cell repertoire data. Bmc Bioinformatics. 2017;18:129.","DOI":"10.1186\/s12859-017-1544-9"},{"issue":"95","key":"625_CR31","doi-asserted-by":"publisher","first-page":"95ra73","DOI":"10.1126\/scitranslmed.3002842","volume":"3","author":"M. Kalos","year":"2011","unstructured":"Kalos M, Levine BL, Porter DL, Katz S, Grupp SA, Bagg A, et al. T Cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci Transl Med. 2011;3:95ra73.","journal-title":"Science Translational Medicine"},{"key":"625_CR32","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1182\/blood-2011-10-384388","volume":"119","author":"JN Kochenderfer","year":"2012","unstructured":"Kochenderfer JN, Dudley ME, Feldman SA, Wilson WH, Spaner DE, Maric I, et al. B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. Blood. 2012;119:2709\u201320.","journal-title":"Blood"},{"key":"625_CR33","doi-asserted-by":"crossref","unstructured":"Yu SN, Li AP, Liu Q, Li TF, Yuan X, Han XW, et al. Chimeric antigen receptor T cells: a novel therapy for solid tumors. J Hematol Oncol. 2017; 10.","DOI":"10.1186\/s13045-017-0444-9"},{"key":"625_CR34","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2174\/1389450116666150304103849","volume":"18","author":"FK Elizabeth","year":"2017","unstructured":"Elizabeth FK, Hui-Sheng A, Brian S, Jean-Sebastien D, Kai-Xun H, Anthony DS. Do we need full donor chimerism? How alloreactive cell therapies without substantial engraftment might treat Hematologic cancers. Curr Drug Targets. 2017;18:281\u201395. https:\/\/doi.org\/10.2174\/1389450116666150304103849","journal-title":"Curr Drug Targets"},{"key":"625_CR35","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1200\/JCO.2012.42.0281","volume":"30","author":"M Guo","year":"2012","unstructured":"Guo M, Hu KX, Liu GX, Yu CL, Qiao JH, Sun QY, et al. HLA mismatched stem-cell Microtransplantation as postremission therapy for acute myeloid leukemia: long-term follow-up. J Clin Oncol. 2012;30:4084\u201390.","journal-title":"J Clin Oncol"},{"key":"625_CR36","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1182\/blood-2013-08-523001","volume":"123","author":"P Bachireddy","year":"2014","unstructured":"Bachireddy P, Hainz U, Rooney M, Pozdnyakova O, Aldridge J, Zhang WD, et al. Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusion. Blood. 2014;123:1412\u201321.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0625-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0625-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0625-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:15:14Z","timestamp":1684617314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-019-0625-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,5]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["625"],"URL":"https:\/\/doi.org\/10.1038\/s41409-019-0625-y","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,5]]},"assertion":[{"value":"13 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}